| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | CRMD | United States | $6.45 | $311,709,000.00 | Strong Buy | 6 | 2009 |
#2 | ENR | United States | $17.01 | $2,952,700,000.00 | Buy | 7 | 2015 |
#3 | FIVN | United States | $15.76 | $1,149,088,000.00 | Buy | 19 | 2014 |
#4 | VRRM | United States | $14.96 | $132,969,000.00 | Buy | 5 | 2016 |
#5 | XHR | United States | $14.17 | $1,078,500,000.00 | Buy | 6 | 2014 |
#6 | ORN | United States | $10.27 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#7 | ARI | United States | $10.27 | $271,589,000.00 | Buy | 4 | 2009 |
#8 | LEVI | United States | $17.93 | $6,282,000,000.00 | Strong Buy | 13 | 2019 |
#9 | AMRX | United States | $11.83 | $0.00 | Strong Buy | 4 | 2018 |
#10 | LC | United States | $13.80 | $314,702,000.00 | Buy | 6 | 2008 |
#11 | CYRX | United States | $7.82 | $176,177,000.00 | Strong Buy | 9 | 2008 |
#12 | BXMT | United States | $18.57 | $0.00 | Buy | 5 | 1998 |
#13 | KROS | United States | $11.02 | $243,864,000.00 | Buy | 8 | 2020 |
#14 | YEXT | United States | $5.23 | $170,201,000.00 | Buy | 4 | 2017 |
#15 | OPRX | United States | $6.40 | $109,429,000.00 | Strong Buy | 6 | 2008 |
#16 | HLMN | United States | $8.06 | $1,552,224,000.00 | Strong Buy | 5 | 2020 |
#17 | RUN | United States | $12.19 | $858,578,000.00 | Buy | 19 | 2015 |
#18 | APLS | United States | $18.95 | $1,003,782,000.00 | Buy | 20 | 2015 |
#19 | NMRK | United States | $14.21 | $3,294,024,000.00 | Buy | 6 | 2017 |
#20 | XERS | United States | $5.46 | $49,590,000.00 | Strong Buy | 7 | 2021 |
#21 | ALHC | United States | $17.03 | $3,948,719,000.00 | Buy | 10 | 2021 |
#22 | CRNC | United States | $7.02 | $251,781,000.00 | Buy | 4 | 2019 |
#23 | WWW | United States | $15.98 | $1,874,300,000.00 | Buy | 9 | 2001 |
#24 | AVAH | United States | $6.96 | $2,024,506,000.00 | Buy | 9 | 2021 |
#25 | CERT | United States | $6.65 | $418,838,000.00 | Buy | 10 | 2020 |
#26 | MBLY | Israel | $7.57 | $1,894,000,000.00 | Buy | 19 | 2022 |
#27 | QUBT | United States | $7.31 | $682,000.00 | Strong Buy | 5 | 2019 |
#28 | AVTX | United States | $15.80 | $27,813,137.00 | Strong Buy | 9 | 2015 |
#29 | PTON | United States | $3.71 | $0.00 | Buy | 13 | 2019 |
#30 | LXEO | United States | $6.66 | $654,000.00 | Strong Buy | 10 | 2023 |
#31 | SHC | United States | $13.42 | $1,163,617,000.00 | Buy | 7 | 2020 |
#32 | NRDS | United States | $9.93 | $836,600,000.00 | Buy | 6 | 2021 |
#33 | COMP | United States | $8.27 | $6,961,600,000.00 | Strong Buy | 10 | 2021 |
#34 | AMLX | United States | $13.99 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#35 | ADPT | United States | $13.17 | $276,976,000.00 | Strong Buy | 9 | 2019 |
#36 | ARRY | United States | $6.93 | $1,284,141,000.00 | Buy | 19 | 2020 |
#37 | TSHA | United States | $4.49 | $8,333,000.00 | Strong Buy | 9 | 2020 |
#38 | DRVN | United States | $10.34 | $2,339,588,000.00 | Buy | 8 | 2020 |
#39 | PHR | United States | $10.97 | $419,813,000.00 | Strong Buy | 17 | 2019 |
#40 | ARVN | United States | $12.18 | $262,600,000.00 | Buy | 21 | 2018 |
#41 | CADL | United States | $4.67 | $125,000.00 | Strong Buy | 6 | 2021 |
#42 | BLZE | United States | $3.64 | $145,835,000.00 | Strong Buy | 6 | 2021 |
#43 | SGRY | United States | $12.38 | $1,145,438,000.00 | Buy | 8 | 2015 |
#44 | AOMR | United States | $8.20 | $0.00 | Strong Buy | 4 | 2019 |
#45 | HCSG | United States | $19.54 | $1,837,173,000.00 | Buy | 6 | 1994 |
#46 | CRVS | United States | $15.32 | $0.00 | Strong Buy | 5 | 2016 |
#47 | MXL | United States | $16.89 | $478,596,000.00 | Buy | 5 | 2009 |
#48 | REAL | United States | $9.56 | $692,845,000.00 | Buy | 8 | 2019 |
#49 | BCYC | United Kingdom | $4.78 | $0.00 | Buy | 9 | 2019 |
#50 | SHLS | United States | $6.13 | $475,331,000.00 | Buy | 14 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (March 14, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.